Four observational studies regarding outcomes of COVID patients treated with ACEI and ARB were published in May 2020. More than 22,000 patients were analyzed at Bringham and Woman’s Hospital, University of Milano, NYU Grossman School of Medicine, and the Cleveland Clinic with overall results that do not suggest continued use of ACE inhibitors or ARBs contribute to the severity of COVID 19 in patients.